Literature DB >> 9188653

pIRS1 and pTRS1 are present in human cytomegalovirus virions.

M J Romanowski1, E Garrido-Guerrero, T Shenk.   

Abstract

The virus-coded proteins pIRS1 and pTRS1 were found associated with purified human cytomegalovirus virions. The proteins were not degraded when intact virions were treated with trypsin, which suggests that they are localized inside the viral particle. In transfection experiments pIRS1 and pTRS1 modestly activated expression from a reporter plasmid containing the viral major immediate-early promoter but did not influence the activity of a reporter carrying the irs1/trs1 immediate-early promoter. Both reporters were activated by the combination of pIRS1 or pTRS1 and pUL69, which is also present in virions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188653      PMCID: PMC191821          DOI: 10.1128/JVI.71.7.5703-5705.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  11 in total

1.  Proteins associated with purified human cytomegalovirus particles.

Authors:  C J Baldick; T Shenk
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

2.  Characterization of the human cytomegalovirus irs1 and trs1 genes: a second immediate-early transcription unit within irs1 whose product antagonizes transcriptional activation.

Authors:  M J Romanowski; T Shenk
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

3.  Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus.

Authors:  A Irmiere; W Gibson
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

4.  A specific subform of the human cytomegalovirus transactivator protein pUL69 is contained within the tegument of virus particles.

Authors:  M Winkler; T Stamminger
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Human cytomegalovirus: purification of enveloped virions and dense bodies.

Authors:  P Talbot; J D Almeida
Journal:  J Gen Virol       Date:  1977-08       Impact factor: 3.891

6.  Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infection.

Authors:  J A Kerry; M A Priddy; T Y Jervey; C P Kohler; T L Staley; C D Vanson; T R Jones; A C Iskenderian; D G Anders; R M Stenberg
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

7.  Four of eleven loci required for transient complementation of human cytomegalovirus DNA replication cooperate to activate expression of replication genes.

Authors:  A C Iskenderian; L Huang; A Reilly; R M Stenberg; D G Anders
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2.

Authors:  P C Stasiak; E S Mocarski
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

9.  Identification and procaryotic expression of the gene coding for the highly immunogenic 28-kilodalton structural phosphoprotein (pp28) of human cytomegalovirus.

Authors:  H Meyer; A T Bankier; M P Landini; C M Brown; B G Barrell; B Rüger; M Mach
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

10.  Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements.

Authors:  B Liu; M F Stinski
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

View more
  30 in total

1.  Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle.

Authors:  M L Hayashi; C Blankenship; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Mutant human cytomegalovirus lacking the immediate-early TRS1 coding region exhibits a late defect.

Authors:  Catherine A Blankenship; Thomas Shenk
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein.

Authors:  Ileana M Cristea; Nathaniel J Moorman; Scott S Terhune; Christian D Cuevas; Erin S O'Keefe; Michael P Rout; Brian T Chait; Thomas Shenk
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

4.  Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein.

Authors:  Claudia Mack; Albert Sickmann; David Lembo; Wolfram Brune
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

5.  Human cytomegalovirus UL28 and UL29 open reading frames encode a spliced mRNA and stimulate accumulation of immediate-early RNAs.

Authors:  Dora P Mitchell; John P Savaryn; Nathaniel J Moorman; Thomas Shenk; Scott S Terhune
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

6.  Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection.

Authors:  Kevin A Cassady
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Human cytomegalovirus pUS24 is a virion protein that functions very early in the replication cycle.

Authors:  Xuyan Feng; Jörg Schröer; Dong Yu; Thomas Shenk
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Analysis of the role of autophagy inhibition by two complementary human cytomegalovirus BECN1/Beclin 1-binding proteins.

Authors:  Lina Mouna; Eva Hernandez; Dorine Bonte; Rebekka Brost; Larbi Amazit; Laura R Delgui; Wolfram Brune; Adam P Geballe; Isabelle Beau; Audrey Esclatine
Journal:  Autophagy       Date:  2016       Impact factor: 16.016

9.  Multiple Transcripts Encode Full-Length Human Cytomegalovirus IE1 and IE2 Proteins during Lytic Infection.

Authors:  Kyle C Arend; Benjamin Ziehr; Heather A Vincent; Nathaniel J Moorman
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

10.  Human cytomegalovirus UL69 protein induces cells to accumulate in G1 phase of the cell cycle.

Authors:  M Lu; T Shenk
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.